1959

Founder Mr. Johnson Huang started the company Johnson Chemical Pharmaceutical Works in June

1961

Started construction of new plant at current manufacturing site in July and completed in July of 1962

1963

Technical corporation with Taisho Pharmaceutical Co., Ltd. and manufactured Opyrin

1964

Expanded manufacturing site

1966

Johnson Chemical Pharmaceutical Works Ltd. was founded with an initial capital of NT$720,000

1979

Accumulated capital amounts to NT$43,300,000

1980

JCP acquired the corporate office building at 31, Sec.4, San Ho Road,
San Chung District, New Taipei City

1986

Started the construction of a new GMP plant and finished in 1988

1988

GMP certified

2000

Accumulated capital amounts to NT$119,900,000

2003

JCP acquired current manufacturing site at 77, Sec.4, San Ho Road,
San Chung District, New Taipei City

2005

cGMP certified

2007

Change of corporate name to Johnson Chemical Pharmaceutical Works Co., Ltd.

2009

Accumulated capital amounts to NT$145,000,000

FSC (Financial Supervisory Commission) approves public offering of common stock

2010

Issued emerging stock with stock symbol: 4747

JCP is PIC/S GMP certified by TFDA (Taiwan Food and Drug Administration)

2012

Accumulated capital amounts to NT$180,000,000

2013

Cash capital increased by NT$27,000,000 with total accumulated capital amounting

NT$229,500,000

IPO listed on Taipei Exchange

2014

Accumulated capital amounts to NT$258,187,500

2015

JCP acquired land in YiLan county

2019

JCP reinvested Pei Jin International Co., Ltd.

2020

JCP acquired land in San Chong District